Subject: PSID Interview Sheds Light on Recent Big Acquisition News

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
PSID Interview Sheds Light on Recent Big Acquisition News
Top PerformerYesterday's Top Performer

PositiveID Corporation (OTCQB: PSID)

End of Day:

Price: 0.037

Change (%): + 0.0065 (21.31)

Volume: 20,221,767
PSID Chart

PositiveID Corporation Discusses Recent Acquisition Announcement in New Interview at

AUSTIN, Texas, Oct. 27, 2015 (GLOBE NEWSWIRE) -, Inc. today announced it conducted a new audio interview with PositiveID Corporation (“PositiveID” or the “Company”) (OTCQB:PSID), a developer of biological detection and diagnostics solutions. In the interview, which can be heard at, William J. Caragol, Chairman and CEO of PositiveID, discusses the Company’s recent acquisition news and overall acquisition strategy.

Last week PositiveID announced it entered into an agreement to acquire Thermomedics Inc. and the FDA-cleared Caregiver® non-contact thermometer. The acquisition is a part of the Company’s overall growth strategy to add revenue-generating, complementary products with significant market penetration potential to its portfolio. PositiveID expects to close the acquisition during the fourth quarter of 2015.

Continue Reading

Other Small Cap News

Company: Plandaí Biotechnology, Inc. (OTCQB: PLPL)

Plandai Biotechnology, Inc. Announces Distribution Agreement With Bal Pharma Ltd Covering India

LONDON, UNITED KINGDOM--(Marketwired - Oct 27, 2015) - Plandaí Biotechnology, Inc. ("Plandaí" or "the Company") (OTCQB: PLPL), producer of the highly bioavailable Phytofare®, today announced that it has executed an Exclusive Distribution Agreement with Bal Pharma Ltd., an India-based manufacturer and exporter of pharmaceutical finished formulation/bulk drugs and distributor of nutraceuticals ingredients ( Under the terms of the agreement, Bal Pharma will use the Company's Phytofare® in their finished formulation products while also distributing Phytofare® as an active ingredient throughout India. The two-year renewable agreement gives Bal Pharma exclusivity for their territory and fixed pricing based on volume in exchange for defined annual off take.

Callum Cottrell-Duffield, Vice President of Sales for Plandaí, commented, "Bal Pharma is one of the leading pharmaceutical companies operating in both the Indian and International market and we're excited to partner with them to bring Phytofare® to the region. With their proven track record as the manufacturer, exporter and distributor of pharmaceutical finished formulation/bulk drugs, Bal Pharma should quickly be able to generate substantial market penetration for Plandaí. Our agreement with such a highly-regarded Indian company further validates the fifteen years of research that has gone into bringing Phytofare® to market and the solid science behind our phyto-available products."

Continue Reading

Company: Quadrant 4 Systems Corp (Pink Sheets: QFOR)

Quadrant 4 Systems Corporation Announced as Newest Member of The Private Exchange Coalition "PEC"

SCHAUMBURG, Ill., Oct. 27, 2015 (GLOBE NEWSWIRE) -- Quadrant 4 System Corporation (QFOR) ("Quadrant 4" or the "Company"), a leading technology company offering state-of-the art SaaS (Software as a Service) and PaaS (Platform as a Service) based Exchange Solutions, today announces it has joined the The Private Exchange Coalition (PEC) as a new member. PEC is the premier industry association for organizations affiliated with private exchanges and includes the following firms, Connecture, Array Health, Bloom Health, ConnectedHealth, Softheon and Leavitt Partners.

The Private Exchange Coalition (PEC) was originally formed by five industry-leading private exchange technology vendors as a means to promote shared industry standards, best practices and increase awareness of the powerful ways private exchanges improve the selection, administration and use of employee benefits. PEC aims to help establish private exchanges as a long-term solution for enabling consumers to easily evaluate and select employee benefits that best meet their health care, economic and lifestyle needs. The PEC will be a catalyst for bringing best in class e-commerce solutions to the employer-sponsored insurance market.

Continue Reading

Company: Harrison, Vickers and Waterman, Inc. (OTCBB: HVCW)

Harrison, Vickers and Waterman, Inc. ("HVCW") Announces the Agreement to Build Its Next WOB Tavern in Cambridge, Massachusetts

NORTH PALM BEACH, FL--(Marketwired - Oct 27, 2015) - Harrison, Vickers and Waterman, Inc. (OTCBB: HVCW): Attitude Drinks, Inc. (OTC PINK: ATTD) announced today that its JV partner, New England WOB LLC, has signed a definitive lease agreement for a location in the prestigious CambridgeSide Galleria in the Cambridge/Boston, Massachusetts area. As with previous agreements in West Hartford and Milford, Connecticut, the Company has agreed to fund this new venture whereby HVCW will own 51% of the tavern while the restaurant will be operated by New England WOB LLC.

This CambridgeSide Galleria location enjoys a number of extraordinary attributes including a 4,300 square foot location with internal and external access. The Galleria represents a total of one million square feet, has over seven million visitors annually, 2,500 parking spaces and 630 adjacent hotel rooms. There are 250,000 college students in the Cambridge/Boston area and the Galleria is surrounded by twenty million square feet of office and R&D space. Construction will begin in January and operations should commence by spring 2016.

Continue Reading

Company: True Drinks Holdings, Inc. (OTCBB: TRUU)

True Drinks Announces Partnership With Niagara Bottling

True Drinks Continues to Innovate With New Zero-Sugar, Clean Label Formulation for AquaBall

IRVINE, CA--(Marketwired - October 27, 2015) - True Drinks Holdings, Inc. (OTCBB: TRUU), a healthy beverage provider with licensing agreements with Disney and Marvel for use of their characters on its proprietary, patented bottles, today announced a Bottling Agreement with Niagara Bottling, LLC for the production of AquaBall™ Naturally Flavored Water. With Niagara, True Drinks will produce an improved "clean label" preservative free formulation of AquaBall which will remain sugar and calorie free.

Lance Leonard, Chief Executive Officer of True Drinks, stated, "We are excited to announce this partnership and move our operations to the beverage industry leader in efficiency and quality. This move allows True Drinks to focus resources on the sales and marketing of AquaBall Naturally Flavored Water and removes the capital-intensive process of procurement, transportation and manufacturing of our product."

Continue Reading

Market News

By Evelyn Cheng: CNBC

US stocks open lower after durable goods; earnings eyed

U.S. stocks opened lower Tuesday under pressure from economic reports and ahead of major quarterly earnings.

"The market's looking at earnings and of course economic statistics. I think we got off to a little bit of a bad start this morning with the durable goods," said Ben Pace, chief investment officer at HPM Partners.

Durable goods orders showed a decline of 1.2 percent in September.

Continue Reading

By Peter Schacknow:

Early movers: DD, F, MRK, PFE, CMCSA, BABA, VRX, SAVE, BMY, F & more

Check out which companies are making headlines before the bell:

DuPont - The chemical giant earned an adjusted 13 cents per share for the third quarter, 3 cents above estimates. Revenue was well short, however, as a strong dollar and other factors impacted the bottom line. DuPont said it was "not pleased" with the quarter's results.

Ford Motor - Ford reported adjusted quarterly profit of 45 cents per share, a penny shy of estimates. Revenue, however, was above forecasts, and Ford said its North American unit had its best quarter ever.

Merck - Merck earned an adjusted 96 cents per share for the third quarter, beating estimates by 5 cents, with revenue essentially in line. Merck also increased its full-year forecast, even as it suffers negative impact from a stronger dollar.

Continue Reading

Like Us on FacebookFollow Us on Twitter

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks